Instrumentation and Techniques For Therapeutic Drug Monitoring

References

1. • Anderson R.J.
   • Sternberg J.C.
   A rate nephelometer for immunoprecipitin measurement of specific serum proteins.
   in: Ritchie F.R. Automated Immunoanalysis. Vol. 2. Marcel Dekker, Inc., New York1978
   • Google Scholar
2. • Baselt R.C.
   Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology.
   Biomedical Publications, Davis, California1980
   • Google Scholar

3. Bernstein, D., Standiford, H., and Reynolds, J.: Abstract presented at 18th Interscience Conference on Antimicrobial Agents and Chemotherapy, October, 1978.

   • Google Scholar
4. • Biggs J.T.
   Tricyclic antidepressant plasma measurements in clinical practice.
   in: Baer D.M. Dito W.R. Interpretations in Therapeutic Drug Monitoring. American Society of Clinical Pathologists, Chicago1980
   • Google Scholar
5. • Blume P.
   • Greenberg L.J.
   Application of differential light scattering to the latex agglutination assay for rheumatoid factor.
   Clin. Chem. 1975; 21: 1234
   • PubMed
   • Google Scholar
6. • Boguslaski R.C.
   • Li T.M.
   • Benovic J.L.
   • et al.
   Substrate labeled homogeneous fluorescent immunoassays for haptens and proteins.
   in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays Clinical Laboratory Techniques for the 1980’s. Alan R. Liss, Inc., New York1980
   • Google Scholar
7. • Brodie B.B.
   • Mitchell J.R.
   The value of correlating biological effects of drugs with plasma concentration.
   in: Davies D.S. Prichard B.N.C. Biological Effects of Drugs in Relation to their Plasma Concentrations. University Park Press, Baltimore1973: 1-12
   • Google Scholar
8. • Cambiaso C.L.
   • Leek A.E.
   • DeSteenwinkel F.
   • et al.
   Particle counting immunoassay (PA-CIA). 1. A general method for the determination of antibodies, antigens, and haptens.
   J. Immunol. 1977; 18: 33
   • Google Scholar
9. • Currey R.E.
   • Heitzman H.
   • Riege D.H.
   • et al.
   A systems approach to fluorescent immunoassay: General principles and representative applications.
   Clin. Chem. 1979; 25: 1591
   • PubMed
   • Google Scholar
10. • Dandliker W.B.
    • Kelly R.J.
    • Dandliker J.
    Fluorescence polarization immunoassay. Theory and experimental method.
    Immunochemistry. 1973; 10: 219
    • Scopus (192)
    • PubMed
    • Crossref
    • Google Scholar
11. • Davies G.E.
    The use of a sensitive micronephelometer in the estimation of antigens and precipitating antibodies.
    Immunology. 1971; 20: 779
    • PubMed
    • Google Scholar
12. • Dito W.R.
    Quantitation of rheumatoid factor by latex particle aggregation measurement.
    Am. J. Clin. Pathol. 1978; 69: 147
    • Scopus (5)
    • PubMed
    • Crossref
    • Google Scholar
13. • Engvall E.
    • Perlmann P.
    Enzyme-linked immunosorbent assays (ELISA): Quantitative assay of immunoglobulin G.
    Immunochemistry. 1971; 8: 871
    • Scopus (2871)
    • PubMed
    • Crossref
    • Google Scholar
14. • Gerson B.
    • Anhalt J.P.
    High Pressure Liquid Chromatography and Therapeutic Drug Monitoring.
    American Society of Clinical Pathologists, Chicago1980
    • Google Scholar
15. • Haas M.J.
    • Davies J.
    Enzymatic acetylation as a means of determining serum amino glycoside concentrations.
    Antimicrob. Agents Chemother. 1973; 4: 497
    • Scopus (51)
    • PubMed
    • Crossref
    • Google Scholar
16. • Hamilton R.J.
    • Sewell P.A.
    Introduction to High Performance Liquid Chromatography.
    John Wiley and Sons, New York1977
    • Google Scholar
17. • Keffer J.H.
    High pressure liquid chromatography: An evaluation of basic principles and laboratory potential.
    in: Interpretation in Therapeutic Drug Monitoring. American Society of Clinical Pathologists, Chicago1981
    • Google Scholar
18. • Kronick M.N.
    • Little W.A.
    A new immunoassay based on fluorescence excitation by internal reflection spectroscopy.
    J. Immunol. Methods. 1975; 8: 235
    • Scopus (107)
    • PubMed
    • Crossref
    • Google Scholar
19. • Lasky F.D.
    • Ahuja K.K.
    • Karmen A.
    Enzyme immunoassays with the miniature centrifugal fast analyzer.
    Clin. Chem. 1977; 23: 1444
    • PubMed
    • Google Scholar
20. • Maggio E.T.
    Recent advances in heterogeneous fluorescent immunoassays.
    in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays Clinical Laboratory Techniques for the 1980’s. Alan R. Liss, Inc., New York1980
    • Google Scholar
21. • Mitruka B.M.
    Gas chromatographic applications in microbiology and medicine.
    John Wiley and Sons, New York1975
    • Google Scholar
22. • Nakamura R.M.
    Fluorescent antibody methods. Quality assurance procedures.
    in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays in the Clinical Laboratory. Alan R. Liss, Inc., New York1979
    • Google Scholar
23. • Nakamura R.M.
    Recent advances in immunochemical fluorescent analytical methods.
    in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays in the Clinical Laboratory. Alan R. Liss, Inc., New York1979
    • Google Scholar
24. • Nargessi R.D.
    • Landon J.
    • Smith D.S.
    Use of antibodies against the label in nonseparation non-isotopic immunoassay: “Indirect quenching” fluoroimmunoassay of proteins.
    J. Immunol. Methods. 1979; 23: 307
    • Scopus (15)
    • Crossref
    • Google Scholar
25. • Nishikawa T.
    • Kubo H.
    • Saito M.
    Competitive nephelometric immunoassay of theophylline in plasma.
    Clin. Chem. Acta. 1979; 91: 59
    • Scopus (22)
    • PubMed
    • Crossref
    • Google Scholar
26. • O’Sullivan M.J.
    • Bridges J.W.
    • Marks V.
    Enzyme immunoassay: A review.
    Ann. Clin. Biochem. 1979; 16: 221
    • Scopus (80)
    • PubMed
    • Crossref
    • Google Scholar
27. • Oxley D.K.
    Radioimmunoassay.
    in: Baer D.M. Dito W.R. Interpretations in Therapeutic Drug Monitoring. American Society of Clinical Pathologists, Chicago1981
    • Google Scholar
28. • Pipenger C.
    • Fonesca I.
    • Gambino R.
    • et al.
    An evaluation of phenobarbitol and phenytonin methods for the DuPont ACA.
    DuPont Co., ACA Division, Wilmingto, DelawareSeptember 1978
    • Google Scholar
29. • Rubenstein K.E.
    • Schneider R.S.
    • Ullman E.F.
    “Homogeneous” enzyme immunoassay. A new immunochemical technique.
    Biochem. Biophys. Res. Commun. 1972; 47: 846
    • Scopus (425)
    • PubMed
    • Crossref
    • Google Scholar
30. • Schall R.F.
    • Tenoso H.J.
    Recent developments in heterogeneous enzyme immunoassays.
    in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays Clinical Laboratory Techniques for the 1980’s. Alan R. Liss, Inc., New York1980
    • Google Scholar

31. Tracy, Y., Wilson, L., Rehbinder, D., et al.: A solid phase immunofluorescence method (FIAX) for determination of gentamicin in serum (abstract). Los Angeles, American Society of Microscopists Annual Meeting, 1979.

    • Google Scholar
32. • Ullman E.F.
    • Bellet N.F.
    • Brinkley J.M.
    • et al.
    Homogeneous fluorescent immunoassays.
    in: Nakamura R.M. Dito W.R. Tucker E.S. Immunoassays Clinical Laboratory Techniques for the 1980’s. Alan R. Liss, Inc., New York1980
    • Google Scholar
33. • Ullman E.F.
    • Schwartzberg M.
    • Rubenstein K.D.
    Fluorescent excitation transfer assay—A general method for determination of antigen.
    J. Biol. Chem. 1976; 251: 4172
    • PubMed
    • Google Scholar
34. • Van Weeman B.
    • Schuurs A.
    Immunoassay using antigen-enzyme conjugates.
    FEBS Lett. 1971; 15: 232
    • Scopus (690)
    • PubMed
    • Crossref
    • Google Scholar
35. • Werner M.
    • Mohrbacher R.J.
    • Riendean C.J.
    Gas-liquid chromatography of underivatized drugs after chromatographic extraction from blood.
    Clin. Chem. 1979; 25: 2020
    • PubMed
    • Google Scholar
36. • Zuk R.F.
    • Rowley G.L.
    • Ullman E.F.
    Fluorescence protection immunoassay: A new homogeneous assay technique.
    Clin. Chem. 1979; 25: 1554
    • PubMed
    • Google Scholar